Coronavirus: testing of a vaccine suspended



[ad_1]

Most of the content in the portfolio is available for free, as is this article.

However, the situation in the media market is constantly changing: if you want to support quality business journalism and want to be part of the Portfolio community, subscribe to Portfolio Signature articles. Know more

Trials are currently underway in the final part of a three-phase clinical trial in which the vaccine was administered to thousands of people to test its efficacy and safe use. Johnson and Johnson said last month that it intends to involve 60,000 people on three continents in the third phase of the experiments.

However, a report said Monday that diseases, even serious ones, usually occur during a clinical trial and are expected to show up in large numbers in larger trials. It was also found that there is a difference in announcing the suspension of trials at the trial level than when a health authority orders the same.

The company highlighted its strong commitment to the safe use of the vaccine. It also noted that the subject’s illness was being examined by company doctors, as well as health professionals from independent inspection bodies.

Cover image: Getty Images



[ad_2]